Immunization with live influenza viruses in an experimental model of allergic bronchial asthma: Infection and vaccination

Influenza and other Respiratory Viruses

Volumn 2, Issue 5, 2008, Pages 165-174

  Chirkova, Tatiana ^a   Petukhova, Galina ^a   Korenkov, Daniil ^a   Naikhin, Anatoliy ^a   Rudenko, Larisa ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

Author keywords

Asthma; Influenza infection; Live attenuated influenza vaccine

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; INFLUENZA VACCINE; INTERLEUKIN 4; OVALBUMIN;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DRUG SAFETY; EXPERIMENTAL MODEL; FEMALE; HISTOPATHOLOGY; IMMUNOGLOBULIN PRODUCTION; INFLAMMATORY INFILTRATE; INFLUENZA; INFLUENZA VACCINATION; LUNG PARENCHYMA; LYMPHOCYTE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; REMISSION; SPLEEN;

ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOGLOBULIN E; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERLEUKIN-4; LUNG; MICE; SPLEEN; T-LYMPHOCYTES; VACCINES, ATTENUATED;

EID: 57649188675     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2008.00061.x     Document Type: Article

References (30)

1. Burrows B. Airways obstructive diseases: Pathogenetic mechanisms and natural histories of the disorders. Med Clin North Am 1990; 74: 547-559.
2. Braman SS. The global burden of asthma. Chest 2006; 130: 4S-12S.
3. Tan WC, Xiang X, Qiu D, Ng TP, Lam SF, Hegele RG. Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease. Am J Med 2003; 115: 272-277.
4. Mullooly JP, Bridges CB, Thompson WW et.al. Influenza- and RSV-associated hospitalizations among adults. Vaccine 2007; 25: 846-855.
5. Miller EK, Griffin MR, Edwards KM et.al. Influenza burden for children with asthma. Pediatrics 2008; 121: 1-8.
6. Dombkowski KJ, Davis MM, Cohn LM, Clark SJ. Effect of missed opportunities on influenza vaccination rates among children with asthma. Arch Pediatr Adolesc Med 2006; 160: 966-971.
7. Lyn-Cook R, Halm EA, Wisnivesky JP. Determinants of adherence to influenza vaccination among inner-city adults with persistent asthma. Prim Care Respir J 2007; 16: 229-235.
8. Fiore AE, Shay DK, Haber P et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 2007; 56: 1-54.
9. Abadoglu O, Mungan D, Pasaoglu G, Celík G, Misirligil Z. Influenza vaccination in patients with asthma: Effect on the frequency of upper respiratory tract infections and exacerbations. J Asthma 2004; 41: 279-283.
10. Bueving HJ, Bernsen RM, de Jongste JC et al. Influenza vaccination in children with asthma: Randomized double-blind placebo-controlled trial. Am J Respir Crit Care Med 2004; 169: 488-493.
11. Christy C, Aligne CA, Auinger P, Pulcino T, Weitzman M. Effectiveness of influenza vaccine for the prevention of asthma exacerbations. Arch Dis Child 2004; 89: 734-735.
12. Ashkenazi S, Vertruyen A, Arístegui J et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J 2006; 25: 870-879.
13. Belshe RB, Edwards KM, Vesikari T et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007; 356: 685-696.
14. Redding G, Walker RE, Hessel C et al. Safety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 2002; 21: 44-48.
15. Fleming DM, Crovari P, Wahn U et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 2006; 25: 860-869.
16. Tsitoura DC, Kim S, Dabbagh K, Berry G, Lewis DB, Umetsu DT. Respiratory infection with influenza A virus interferes the induction of tolerance to aeroallergens. J Immunol 2000; 165: 3484-3491.
17. Alexandrova GI, Polezhaev FI, Budilovsky GN et al. Recombinant cold-adapted attenuated influenza A vaccines for use in children: reactogenicity and antigenic activity of cold-adapted recombinants and analysis of isolates from the vaccinees. Infect Immun 1984; 44: 734-739.
18. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938; 27: 493.
19. Hierholzer JC, Suggs MT. Standardized viral hemagglutination and hemagglutination-inhibition tests. I. Standardization of erythrocyte suspensions. Appl Microbiol 1969; 18: 816-823.
20. Naikhin AN, Donina SA, Kustikova IuG, Katorgina LG, Rudenko LG. Monoclonal immunoenzyme test-system for evaluating secretory immunity to influenza A and B viruses. Vopr Virusol 1997; 42: 212-216.
21. Saxena RK, Weissman D, Simpson J, Lewis DM. Murine model of BCG lung infection: Dynamics of lymphocyte subpopulations in lung interstitium and tracheal lymph nodes. J Biosci 2002; 27: 143-153.
22. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
23. Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: Missing immune deviation, reduced immune suppression, or both? Immunology 2004; 112: 352-363.
24. Torres R, Picado C, de Mora F. Use of the mouse to unravel allergic asthma: A review of the pathogenesis of allergic asthma in mouse models and its similarity to the condition in humans. Arch Bronconeumol 2005; 41: 141-152.
25. Holt PG, Vines J, Bilyk N. Effect of influenza virus infection on allergic sensitization to inhaled antigen in mice. Int Arch Allergy Appl Immunol 1988; 86: 121-123.
26. Lebrec H, Sarlo K, Burleson GR. Effect of influenza virus infection on ovalbumin-specific IgE responses to inhaled antigen in the rat. J Toxicol Environ Health 1996; 27: 619-630.
27. Yamamoto N, Suzuki S, Suzuki Y et al. Immune response induced by airway sensitization after influenza A virus infection depends on timing of antigen exposure in mice. J Virol 2001; 75: 499-505.
28. Marsland BJ, Scanga CB, Kopf M, Le Gros G. Allergic airway inflammation is exacerbated during acute influenza infection and correlates with increased allergen presentation and recruitment of allergen-specific T-helper type 2 cells. Clin Exp Allergy 2004; 34: 1299-1306.
29. Poulsen LK, Hummelshoj L. Triggers of IgE class switching and allergy development. Ann Med 2007; 39: 440-456.
30. Dahl ME, Dabbagh K, Liggitt D, Kim S, Lewis DB. Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat Immunol 2004; 5: 337-343.